Infectious Disease Antibodies



Rockland has developed many antibodies through NIH grants, such as an extensive line of Lyme disease antibodies optimized for lateral flow and ELISA assays. Other infectious disease antibodies are optimized for ELISA assays—many with matched pairs as indicated below. By combining basic and applied research principles and working closely with life science researchers, Rockland continually strives to offer highly-characterized antibodies that recognize relevant infectious disease targets.